3 withdrawn. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Withdrawn 3 |
Follow Synchroneuron Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial of Oral SNC-102 in Subjects With Combat-Related Posttraumatic Stress Disorder SNC-102 sustained release tablet - Post-Traumatic Stress Disorders, Posttraumatic Stress Disorders | Phase 2 | Withdrawn | Synchroneuron Inc. | 2016-06-01 | 2016-04-18 | |
| A Trial Evaluating the Efficacy, Safety, and Pharmacokinetics of SNC-102 in Subjects With Tourette Syndrome SNC-102 sustained release tablet - Tourette Syndrome | Phase 2 | Withdrawn | Synchroneuron Inc. | 2015-04-01 | 2021-04-13 | |
| A Phase 2 Trial Evaluating SNC-102 in Drug-Induced Tardive Dyskinesia SNC-102, Placebo - Drug-induced Tardive Dyskinesia | Phase 2 | Withdrawn | Synchroneuron Inc. | 2014-02-01 | 2021-04-13 |
Stress Disorders, Post-Traumatic (1) · Tardive Dyskinesia (1) · Tics (1) · Tourette Syndrome (1)
Acamprosate (2)
United States (2)